|
G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
increases expression multiple interactions |
ISO |
Benzophenoneidum results in increased expression of ALDH1A1 protein ALDH1A1 protein promotes the reaction [Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein] |
CTD |
PMID:28722353 |
|
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
|
|
G |
Ano6 |
anoctamin 6 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of ANO6 protein |
CTD |
PMID:28722353 |
|
NCBI chr15:95,688,724...95,873,353
Ensembl chr15:95,688,724...95,872,632
|
|
G |
Araf |
Araf proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Benzophenoneidum results in increased expression of ARAF protein |
CTD |
PMID:28722353 |
|
NCBI chr X:20,663,946...20,726,760
Ensembl chr X:20,664,053...20,726,758
|
|
G |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of ATP6AP2 protein |
CTD |
PMID:28722353 |
|
NCBI chr X:12,453,998...12,483,290
Ensembl chr X:12,454,040...12,483,288
|
|
G |
Ccdc22 |
coiled-coil domain containing 22 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of CCDC22 protein |
CTD |
PMID:28722353 |
|
NCBI chr X:7,460,048...7,471,659
Ensembl chr X:7,460,048...7,471,756
|
|
G |
Ccdc39 |
coiled-coil domain containing 39 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of CCDC39 protein |
CTD |
PMID:28722353 |
|
NCBI chr 3:33,864,906...33,898,473
Ensembl chr 3:33,866,511...33,898,459
|
|
G |
Cd44 |
CD44 antigen |
increases expression |
ISO |
Benzophenoneidum results in increased expression of CD44 protein |
CTD |
PMID:28722353 |
|
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
|
|
G |
Chtf18 |
CTF18, chromosome transmission fidelity factor 18 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of CHTF18 protein |
CTD |
PMID:28722353 |
|
NCBI chr17:25,938,004...25,946,409
Ensembl chr17:25,937,900...25,946,393
|
|
G |
Commd1 |
COMM domain containing 1 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of COMMD1 protein |
CTD |
PMID:28722353 |
|
NCBI chr11:22,849,728...22,934,539
Ensembl chr11:22,846,136...22,932,382
|
|
G |
Cops7b |
COP9 signalosome subunit 7B |
increases expression |
ISO |
Benzophenoneidum results in increased expression of COPS7B protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:86,510,363...86,534,550
Ensembl chr 1:86,510,626...86,537,097
|
|
G |
Cul3 |
cullin 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of CUL3 protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:80,242,640...80,318,426
Ensembl chr 1:80,242,640...80,318,197
|
|
G |
Dynlt1b |
dynein light chain Tctex-type 1B |
increases expression |
ISO |
Benzophenoneidum results in increased expression of DYNLT1 protein |
CTD |
PMID:28722353 |
|
NCBI chr17:6,697,511...6,703,695
Ensembl chr17:6,697,511...6,703,695
|
|
G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of EIF4G3 protein |
CTD |
PMID:28722353 |
|
NCBI chr 4:137,719,090...137,934,397
Ensembl chr 4:137,720,333...137,935,819
|
|
G |
Fastkd2 |
FAST kinase domains 2 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of FASTKD2 protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:63,769,758...63,792,544
Ensembl chr 1:63,769,773...63,793,814
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
Benzophenoneidum results in increased phosphorylation of H2AX protein |
CTD |
PMID:37527026 |
|
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
Hook3 |
hook microtubule tethering protein 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of HOOK3 protein |
CTD |
PMID:28722353 |
|
NCBI chr 8:26,511,449...26,609,646
Ensembl chr 8:26,511,449...26,609,252
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of HSD17B7 protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:169,777,109...169,796,757
Ensembl chr 1:169,777,104...169,796,810
|
|
G |
Htt |
huntingtin |
increases expression |
ISO |
Benzophenoneidum results in increased expression of HTT protein |
CTD |
PMID:28722353 |
|
NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of IQGAP3 protein |
CTD |
PMID:28722353 |
|
NCBI chr 3:87,989,309...88,028,355
Ensembl chr 3:87,989,278...88,028,355
|
|
G |
Kifap3 |
kinesin-associated protein 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of KIFAP3 protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:163,589,711...163,744,676
Ensembl chr 1:163,607,152...163,744,678
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
ALDH1A1 protein promotes the reaction [Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein]; Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein |
CTD |
PMID:28722353 |
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of MAP2K4 protein |
CTD |
PMID:28722353 |
|
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
|
|
G |
Mbd3 |
methyl-CpG binding domain protein 3 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of MBD3 protein |
CTD |
PMID:28722353 |
|
NCBI chr10:80,228,373...80,235,365
Ensembl chr10:80,228,373...80,235,384
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of MKI67 protein |
CTD |
PMID:37527026 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Noa1 |
nitric oxide associated 1 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of NOA1 protein |
CTD |
PMID:28722353 |
|
NCBI chr 5:77,442,016...77,458,276
Ensembl chr 5:77,442,029...77,457,931
|
|
G |
Nup62 |
nucleoporin 62 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of NUP62 protein |
CTD |
PMID:28722353 |
|
NCBI chr 7:44,465,512...44,481,260
Ensembl chr 7:44,465,512...44,480,236
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of PLCG1 protein |
CTD |
PMID:28722353 |
|
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
|
|
G |
Ppp4r1 |
protein phosphatase 4, regulatory subunit 1 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of PPP4R1 protein |
CTD |
PMID:28722353 |
|
NCBI chr17:66,089,253...66,148,921
Ensembl chr17:66,089,568...66,148,921
|
|
G |
Prim2 |
DNA primase, p58 subunit |
increases expression |
ISO |
Benzophenoneidum results in increased expression of PRIM2 protein |
CTD |
PMID:28722353 |
|
NCBI chr 1:33,492,889...33,708,867
Ensembl chr 1:33,492,891...33,708,876
|
|
G |
Prom1 |
prominin 1 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of PROM1 protein |
CTD |
PMID:28722353 |
|
NCBI chr 5:44,150,963...44,260,850
Ensembl chr 5:44,150,962...44,259,374
|
|
G |
Prorp |
protein only RNase P catalytic subunit |
increases expression |
ISO |
Benzophenoneidum results in increased expression of PRORP protein |
CTD |
PMID:28722353 |
|
NCBI chr12:55,349,422...55,429,276
Ensembl chr12:55,346,362...55,429,318
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
increases expression |
ISO |
Benzophenoneidum results in increased expression of SHMT1 protein |
CTD |
PMID:28722353 |
|
NCBI chr11:60,679,723...60,702,062
Ensembl chr11:60,678,930...60,702,544
|
|
G |
Srsf11 |
serine and arginine-rich splicing factor 11 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of SRSF11 protein |
CTD |
PMID:28722353 |
|
NCBI chr 3:157,716,552...157,742,304
Ensembl chr 3:157,716,110...157,742,276
|
|
G |
Tbc1d15 |
TBC1 domain family, member 15 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of TBC1D15 protein |
CTD |
PMID:28722353 |
|
NCBI chr10:115,031,459...115,087,343
Ensembl chr10:115,033,777...115,087,372
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases expression |
ISO |
Benzophenoneidum results in increased expression of TFAM protein |
CTD |
PMID:28722353 |
|
NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
|
|
G |
Usp24 |
ubiquitin specific peptidase 24 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of USP24 protein |
CTD |
PMID:28722353 |
|
NCBI chr 4:106,173,179...106,303,798
Ensembl chr 4:106,173,417...106,298,519
|
|
G |
Washc5 |
WASH complex subunit 5 |
increases expression |
ISO |
Benzophenoneidum results in increased expression of WASHC5 protein |
CTD |
PMID:28722353 |
|
NCBI chr15:59,203,712...59,246,043
Ensembl chr15:59,203,846...59,246,016
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
brilliant green results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:26177467 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
brilliant green results in increased cleavage of and results in increased activity of CASP7 protein |
CTD |
PMID:26177467 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
brilliant green results in decreased expression of CCND1 protein |
CTD |
PMID:26177467 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ikbke |
inhibitor of kappaB kinase epsilon |
decreases expression |
ISO |
brilliant green results in decreased expression of IKBKE protein |
CTD |
PMID:26177467 |
|
NCBI chr 1:131,182,337...131,207,339
Ensembl chr 1:131,182,080...131,207,344
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
increases expression |
ISO |
brilliant green results in increased expression of LONP1 mRNA |
CTD |
PMID:21215310 |
|
NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
brilliant green inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Txn1 |
thioredoxin 1 |
increases oxidation |
ISO |
brilliant green results in increased oxidation of TXN protein |
CTD |
PMID:21215310 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txn2 |
thioredoxin 2 |
multiple interactions decreases expression affects response to substance |
ISO |
brilliant green results in increased oxidation of and results in increased degradation of TXN2 protein brilliant green results in decreased expression of TXN2 protein TXN2 protein affects the susceptibility to brilliant green |
CTD |
PMID:21215310 |
|
NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
|
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
Gentian Violet promotes the reaction [TP53 protein results in increased expression of BAX mRNA]; pifithrin inhibits the reaction [Gentian Violet promotes the reaction [TP53 protein results in increased expression of BAX mRNA]] |
CTD |
PMID:24535435 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bbc3 |
BCL2 binding component 3 |
multiple interactions |
ISO |
Gentian Violet promotes the reaction [TP53 protein binds to BBC3 promoter]; Gentian Violet promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]; pifithrin inhibits the reaction [Gentian Violet promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]] |
CTD |
PMID:24535435 |
|
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression |
ISO |
Gentian Violet results in decreased expression of BCL2 protein |
CTD |
PMID:27373978 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
Gentian Violet results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:26177467 PMID:27373978 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
Gentian Violet results in increased cleavage of and results in increased activity of CASP7 protein |
CTD |
PMID:26177467 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Gentian Violet results in decreased expression of CCND1 protein |
CTD |
PMID:26177467 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
ISO |
Gentian Violet promotes the reaction [TP53 protein binds to CDKN1A promoter]; Gentian Violet promotes the reaction [TP53 protein results in increased expression of CDKN1A mRNA] |
CTD |
PMID:24535435 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
multiple interactions |
ISO |
Gentian Violet inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Ikbke |
inhibitor of kappaB kinase epsilon |
decreases expression |
ISO |
Gentian Violet results in decreased expression of IKBKE protein |
CTD |
PMID:26177467 |
|
NCBI chr 1:131,182,337...131,207,339
Ensembl chr 1:131,182,080...131,207,344
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
decreases activity |
ISO |
Gentian Violet results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
Gentian Violet inhibits the reaction [NOX1 protein results in decreased activity of TP53 protein] |
CTD |
PMID:24535435 |
|
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
Gentian Violet results in increased cleavage of PARP1 protein |
CTD |
PMID:24535435 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Prdx3 |
peroxiredoxin 3 |
multiple interactions |
ISO |
Gentian Violet promotes the reaction [Thiostrepton affects the expression of PRDX3 protein modified form] |
CTD |
PMID:22761781 |
|
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Gentian Violet inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Sox2 |
SRY (sex determining region Y)-box 2 |
multiple interactions |
ISO |
[Gentian Violet results in decreased phosphorylation of and affects the localization of STAT3 protein] inhibits the reaction [STAT3 protein binds to SOX2 promoter] |
CTD |
PMID:27373978 |
|
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Gentian Violet results in decreased phosphorylation of and affects the localization of STAT3 protein] inhibits the reaction [STAT3 protein binds to SOX2 promoter]; Gentian Violet results in decreased phosphorylation of and affects the localization of STAT3 protein |
CTD |
PMID:27373978 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions affects activity |
ISO |
Gentian Violet inhibits the reaction [NOX1 protein results in decreased activity of TP53 protein]; Gentian Violet promotes the reaction [TP53 protein binds to BBC3 promoter]; Gentian Violet promotes the reaction [TP53 protein binds to CDKN1A promoter]; Gentian Violet promotes the reaction [TP53 protein binds to TP53AIP1 promoter]; Gentian Violet promotes the reaction [TP53 protein results in increased expression of BAX mRNA]; Gentian Violet promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]; Gentian Violet promotes the reaction [TP53 protein results in increased expression of CDKN1A mRNA]; Gentian Violet results in increased stability of and results in increased activity of TP53 protein; pifithrin inhibits the reaction [Gentian Violet promotes the reaction [TP53 protein results in increased expression of BAX mRNA]]; pifithrin inhibits the reaction [Gentian Violet promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]] Gentian Violet affects the activity of TP53 protein |
CTD |
PMID:24535435 PMID:35435491 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Txn2 |
thioredoxin 2 |
decreases expression |
ISO |
Gentian Violet results in decreased expression of TXN2 protein |
CTD |
PMID:22761781 |
|
NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
increases expression multiple interactions increases activity |
EXP ISO |
diminazene aceturate results in increased expression of ACE2 mRNA; diminazene aceturate results in increased expression of ACE2 protein [Lipopolysaccharides co-treated with diminazene aceturate] results in increased expression of ACE2 mRNA; [Lipopolysaccharides co-treated with diminazene aceturate] results in increased expression of ACE2 protein; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; ACE2 protein affects the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]] PD 123319 inhibits the reaction [diminazene aceturate results in increased expression of ACE2 protein] diminazene aceturate results in increased activity of ACE2 protein |
CTD |
PMID:25301841 PMID:26862037 PMID:27550926 PMID:28688122 PMID:31982938 |
|
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of ACTA2 protein |
CTD |
PMID:29977014 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Agt |
angiotensinogen |
increases expression multiple interactions |
EXP ISO |
diminazene aceturate results in increased expression of AGT protein modified form 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; ACE2 protein affects the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]; diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form] diminazene aceturate results in increased expression of AGT protein alternative form |
CTD |
PMID:25301841 PMID:26862037 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA] |
CTD |
PMID:26862037 |
|
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
|
|
G |
App |
amyloid beta precursor protein |
affects expression |
EXP |
diminazene aceturate affects the expression of APP protein alternative form |
CTD |
PMID:31982938 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
diminazene aceturate results in decreased expression of MCP1 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] |
CTD |
PMID:26862037 PMID:29977014 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of COL1A1 protein |
CTD |
PMID:29977014 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions |
ISO |
7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein] |
CTD |
PMID:26862037 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of CYBB protein |
CTD |
PMID:29977014 |
|
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
increases phosphorylation |
EXP |
diminazene aceturate results in increased phosphorylation of GRIN2B protein |
CTD |
PMID:31982938 |
|
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
ISO EXP |
diminazene aceturate results in decreased expression of IL1B mRNA diminazene aceturate results in decreased expression of IL1B protein |
CTD |
PMID:25883526 PMID:31982938 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
diminazene aceturate results in decreased expression of IL6 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:25883526 PMID:26862037 PMID:29977014 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP ISO |
diminazene aceturate results in increased phosphorylation of MAPK1 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:26862037 PMID:31982938 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
decreases phosphorylation |
ISO |
diminazene aceturate results in decreased phosphorylation of MAPK14 protein |
CTD |
PMID:25883526 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
EXP ISO |
diminazene aceturate results in increased phosphorylation of MAPK3 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:26862037 PMID:31982938 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mas1 |
MAS1 oncogene |
increases expression |
EXP |
diminazene aceturate results in increased expression of MAS1 protein |
CTD |
PMID:31982938 |
|
NCBI chr17:13,056,981...13,087,037
Ensembl chr17:13,059,966...13,087,030
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of NCF1 protein |
CTD |
PMID:29977014 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
decreases transport |
ISO |
diminazene aceturate results in decreased transport of NCF2 protein |
CTD |
PMID:29977014 |
|
NCBI chr 1:152,675,904...152,712,743
Ensembl chr 1:152,675,945...152,712,742
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO |
7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:26862037 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of NOS1 mRNA |
CTD |
PMID:25883526 |
|
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Nox1 |
NADPH oxidase 1 |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of NOX1 protein |
CTD |
PMID:29977014 |
|
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
decreases activity decreases expression |
ISO |
diminazene aceturate results in decreased activity of RELA protein diminazene aceturate results in decreased expression of RELA mRNA; diminazene aceturate results in decreased expression of RELA protein |
CTD |
PMID:25883526 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Smad2 |
SMAD family member 2 |
decreases phosphorylation |
ISO |
diminazene aceturate results in decreased phosphorylation of SMAD2 protein |
CTD |
PMID:29977014 |
|
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
|
|
G |
Smad3 |
SMAD family member 3 |
decreases phosphorylation |
ISO |
diminazene aceturate results in decreased phosphorylation of SMAD3 protein |
CTD |
PMID:29977014 |
|
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression decreases secretion |
ISO |
diminazene aceturate results in decreased expression of TNF protein diminazene aceturate results in decreased expression of TNF mRNA; diminazene aceturate results in decreased expression of TNF protein diminazene aceturate results in decreased secretion of TNF protein |
CTD |
PMID:25883526 PMID:29977014 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
ISO |
malachite green results in decreased activity of BCHE protein |
CTD |
PMID:16036213 |
|
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with malachite green] results in increased expression of CCNB1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCNB1 protein |
CTD |
PMID:12616621 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with malachite green] results in increased expression of CCND1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CCND1 protein; malachite green promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] |
CTD |
PMID:10906429 PMID:12616621 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
ISO |
malachite green promotes the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein] |
CTD |
PMID:10906429 |
|
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 protein |
CTD |
PMID:12616621 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 mRNA; [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 protein |
CTD |
PMID:12616621 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
decreases activity multiple interactions |
ISO |
malachite green results in decreased activity of KCNA3 protein [malachite green results in decreased activity of KCNA3 protein] which results in decreased import of Thallium |
CTD |
PMID:21362439 |
|
NCBI chr 3:106,943,486...106,947,223
Ensembl chr 3:106,943,485...106,945,386
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
decreases activity multiple interactions |
ISO |
malachite green results in decreased activity of KCNH2 protein [malachite green results in decreased activity of KCNH2 protein] which results in decreased import of Thallium |
CTD |
PMID:21362439 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Khnyn |
KH and NYN domain containing |
affects response to substance |
ISO |
KHNYN gene SNP affects the susceptibility to malachite green |
CTD |
PMID:25622337 |
|
NCBI chr14:56,122,269...56,136,237
Ensembl chr14:56,122,404...56,136,232
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with malachite green] results in increased expression of PCNA protein; malachite green promotes the reaction [Diethylnitrosamine results in increased expression of PCNA protein] |
CTD |
PMID:10906429 PMID:11831363 PMID:12616621 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Rnf150 |
ring finger protein 150 |
affects response to substance |
ISO |
RNF150 gene SNP affects the susceptibility to malachite green |
CTD |
PMID:25622337 |
|
NCBI chr 8:83,589,889...83,817,900
Ensembl chr 8:83,589,985...83,817,897
|
|